First human tests begin for new drug candidate
NCT ID NCT07473570
Summary
This is an early safety study to see how healthy adults tolerate a new drug called GS3-007a. Researchers will give different doses to small groups of volunteers to check for side effects and measure how the drug moves through the body. The goal is to gather basic safety information before testing the drug in people who are sick.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yuehong Plaza, No. 88 Hongcao Road, Xuhui District, Shanghai
RECRUITINGShanghai, Shanghai Municipality, 200233, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.